Skip to main content

Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study

2023-06-08 15:04:22

Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School

News from our full member the Wilmer Eye Institute – Johns Hopkins

Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.

More information here!

Source and image: Wilmer Eye Institute – Johns Hopkins

More news

These contact lenses give people infrared vision — even with their eyes shut

Sci-fi-style technology uses nanoparticles to convert infrared light into visible light that humans can see. Humans have a new way of seeing infrared light, without the need for clunky night-vision […]

Call for Abstracts – deadline coming up

The 19th Annual Meeting of the WAEH is approaching! You do not want to miss this exciting meeting!   We will be talking about: Meet & network with our global […]

Management Training and Systems Development for Eye Hospital Administrators/Managers

7th Aug – 5th Sep, 2025 LAICO, Madurai.

WAEH April Newsletter

WAEH Webinar How to set up an Internet Hospital? Learnings from EYE & ENT Hospital of Fudan University, Shanghai, China! Register now for the WAEH Webinar about the Internet Hospital […]

New Associate WAEH Member: Ozaki Eye Hospital!

The World Association of Eye Hospitals warmly congratulates Ozaki Eye Hospital from Hyuga, Japan, with their associate membership of the WAEH, as the very first Japanese member! We are looking […]